Cancer treatment has come a long way, but many therapies still struggle with targeting tumor cells without damaging heal...
Echoes of hope: DB-OTO gene therapy pioneers genetic hearing loss treatment DB-OTO Gene therapy: advancing treatment for genetic hearing loss
Regeneron Pharmaceuticals’ gene therapy, DB-OTO, has shown promising initial results in improving hearing for chil...
The Unified Patent Court: a historic turning point in the European patent landscape
The Unified Patent Court(“UPC”) became operational on 1 June 2023: it is a supranational court with exclusiv...
BionIT Labs closes a €5.5 million investment round with CDP Venture Capital Sgr, RIF Srl, Sefea Impact Sgr, SIMEST SpA, and Fondazione ENEA Tech e Biomedical
Investment goal: to make the Adam’s Hand bionic prosthesis the premier product in the American prosthetic market and t...
New Horizons in Type 1 Diabetes: FDA Approval of Lantidra and Emerging Therapies
The FDA has approved Lantidra, a groundbreaking donor-derived pancreatic islet cell therapy for type 1 diabetes, providi...
ThBiomedical Valley 2024: Advancing One Health and Innovation in Mirandola on Friday, June 21
On Friday, June 21, at the Rita Levi Montalcini Auditorium in Mirandola (Modena), in the most important biomedical hub i...